Variables | BPH (−) | BPH (+) | P value | ||
---|---|---|---|---|---|
n | % | n | % | (Chi-square test) | |
n = 547584 | 465485 | 85.0 | 82099 | 15.0 |  |
Age (years) | Â | Â | Â | Â | Â |
  <40 | 28373 | 6.1 | 103 | 0.1 | <0.0001 |
 40-49 | 88077 | 18.9 | 1692 | 2.1 |  |
 50-59 | 144677 | 31.1 | 11014 | 13.4 |  |
 60-69 | 106959 | 23.0 | 22785 | 27.8 |  |
 ≥70 | 97399 | 20.9 | 46505 | 56.7 |  |
Diabetes duration (years) | Â | Â | Â | Â | Â |
 <1 | 43069 | 9.3 | 1921 | 2.3 | <0.0001 |
 1-3 | 83311 | 17.9 | 6379 | 7.8 |  |
 3-5 | 7748 | 16.7 | 9061 | 11.0 |  |
 ≥5 | 261623 | 56.2 | 64738 | 78.9 |  |
Nephropathy | 53002 | 11.4 | 19913 | 24.3 | <0.0001 |
Urinary tract diseases | 59012 | 12.7 | 33818 | 41.2 | <0.0001 |
Hypertension | 248296 | 53.3 | 63518 | 77.4 | <0.0001 |
Chronic obstructive pulmonary disease | 60418 | 13.0 | 25837 | 31.5 | <0.0001 |
Cerebrovascular disease | 59318 | 12.7 | 23756 | 28.9 | <0.0001 |
Ischemic heart disease | 95649 | 20.6 | 33370 | 40.7 | <0.0001 |
Peripheral arterial disease | 52064 | 11.2 | 18708 | 22.8 | <0.0001 |
Eye disease | 75016 | 16.1 | 24855 | 30.3 | <0.0001 |
Dyslipidemia | 231613 | 49.8 | 42928 | 52.3 | <0.0001 |
Heart failure | 25584 | 5.5 | 11400 | 13.9 | <0.0001 |
Obesity | 6360 | 1.37 | 779 | 0.95 | <0.0001 |
Alcohol-related diagnosis | 14797 | 3.18 | 1885 | 2.30 | <0.0001 |
Non-alcohol-related chronic liver disease | 155679 | 33.44 | 30421 | 37.05 | <0.0001 |
Rosiglitazone | 64221 | 13.8 | 16898 | 20.6 | <0.0001 |
Pioglitazone | 22241 | 4.8 | 5191 | 6.3 | <0.0001 |
Sulfonylurea | 365375 | 78.5 | 74154 | 90.3 | <0.0001 |
Meglitinide | 51909 | 11.2 | 14783 | 18.0 | <0.0001 |
Metformin | 325652 | 70.0 | 69254 | 84.4 | <0.0001 |
Acarbose | 68578 | 14.7 | 18395 | 22.4 | <0.0001 |
Insulin | 68122 | 14.6 | 20951 | 25.5 | <0.0001 |
Statin | 133169 | 28.6 | 26302 | 32.0 | <0.0001 |
Fibrate | 106427 | 22.9 | 19705 | 24.0 | <0.0001 |
Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker | 198383 | 42.6 | 52076 | 63.4 | <0.0001 |
Calcium channel blocker | 131769 | 28.3 | 40288 | 49.1 | <0.0001 |
Non-steroidal anti-inflammatory drugs | 303900 | 65.3 | 72262 | 88.0 | <0.0001 |
Alpha-blockers | 50456 | 10.84 | 69086 | 84.15 | <0.0001 |
5-alpha reductase inhibitors | 425 | 0.09 | 3409 | 4.15 | <0.0001 |
Clopidogrel | 14395 | 3.09 | 5346 | 6.51 | <0.0001 |
Ticlopidine | 11315 | 2.43 | 5278 | 6.43 | <0.0001 |
Dipyridamole | 78550 | 16.87 | 30566 | 37.23 | <0.0001 |
Cyclophosphamide | 456 | 0.10 | 147 | 0.18 | <0.0001 |
Diuretics | 103397 | 22.21 | 36462 | 44.41 | <0.0001 |
Other cancer prior to baseline | 41311 | 8.9 | 18433 | 22.5 | <0.0001 |